|
|
Volumn 8, Issue 5, 1997, Pages 415-416
|
|
Chemotherapy for advanced pancreatic cancer - Some light at the end of the tunnel?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOXORUBICIN;
FLUOROURACIL;
GEMCITABINE;
IRINOTECAN;
MARIMASTAT;
MATRIX METALLOPROTEINASE INHIBITOR;
MITOMYCIN C;
OCTREOTIDE;
TAXANE DERIVATIVE;
ADVANCED CANCER;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG POTENTIATION;
EDITORIAL;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PANCREAS CANCER;
PATIENT SELECTION;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
FLUOROURACIL;
HUMANS;
PANCREATIC NEOPLASMS;
|
|
EID: 0030745230
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008292224326 Document Type: Editorial |
|
Times cited : (7)
|
|
References (15)
|
